Evofem Raises $25M

San Diego-based EVOFEM, a biotechnology firm developing new contraceptives for the women's reproductive health market, announced this morning that it has raised $25M in a Series D funding round. The funding came from Woodford Investment Management. According to the company, the funding goes towards clinical and commercialization infrastructure, plus its current pipeline of technology. EVOFEM is led by Saundra Pelletier. More information »